Epidemiology and Population Health

Long-term health outcomes in patients with Prader–Willi Syndrome: a nationwide cohort study in Denmark

Abstract

Background:

Prader–Willi syndrome (PWS) is a rare congenital disease that affects growth, sexual development, cognitive function and behavior. Individuals exhibit food preoccupation and hyperphagia, which may lead to obesity with premature morbidity and mortality. The aim of this work was to evaluate the risk of venous thromboembolisms (VTEs), myocardial infarction, pulmonary hypertension, sleep apnea, depression, anxiety and all-cause mortality among persons with PWS as compared with an age- and sex-matched general-population cohort.

Methods:

All persons diagnosed with PWS (n=155) were identified in the Danish Health Registries; an age- and sex-matched comparison group was selected from the general population of Denmark (n=15 500); diseases of interest were identified through the health registry and cause of death register. Follow-up began on date of birth or first medical record availability through to first occurrence of an outcome of interest; follow-up ceased at emigration from Denmark or end of study. Incidence rates (IRs) were calculated and Cox's proportional hazards models were used to understand the relative risk (RR) of disease.

Results:

The IRs for VTE among patients with PWS was 144 (60–347) per 100 000 person-years. Risks for VTE events and all-cause mortality were 9.4 times (95% confidence interval (CI): 3.7–23.5) and 11.0 times (95% CI: 5.7–21.1) higher, respectively, for patients with PWS versus the general population. Increased risks were also found individually for deep venous thromboses (DVTs) (RR: 9.1; 95% CI: 3.2–25.2), pulmonary embolisms (RR: 11.0; 95% CI: 1.4–86.9), myocardial infarction (RR: 7.2; 95% CI: 1.7–30.2) and anxiety (RR: 2.8; 95% CI: 1.0–7.5). No cases of pulmonary hypertension, sleep apnea or depressive disorders were identified within this PWS cohort.

Conclusions:

Multiple cardiovascular and behavioral illnesses are more likely to occur among patients with PWS than within the general population. These increased risks may provide an impetus for enhanced disease prevention, screening, diagnosis and treatment.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1

References

  1. 1

    Butler MG . Prader–Willi syndrome: obesity due to genomic imprinting. Curr Genomics 2011; 12: 204–215.

    CAS  Article  Google Scholar 

  2. 2

    Rubin L, Merrick J, Greydanus DE, Patel DR. Health Care for People with Intellectual and Developmental Disabilities Across the Lifespan, 2016. Available at: http://dx.doi.org/10.1007/978-3-319-18096-0 (last accessed 6 October 2016).

  3. 3

    Ehara H, Ohno K, Takeshita K . Frequency of the Prader–Willi syndrome in the San-in district, Japan. Brain Dev 1995; 17: 324–326.

    CAS  Article  Google Scholar 

  4. 4

    Lionti T, Reid SM, White SM, Rowell MM . A population-based profile of 160 Australians with Prader–Willi syndrome: trends in diagnosis, birth prevalence and birth characteristics. Am J Med Genet 2015; 167A: 371–378.

    Article  Google Scholar 

  5. 5

    Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H . Population prevalence and estimated birth incidence and mortality rate for people with Prader–Willi syndrome in one UK Health Region. J Med Genet 2001; 38: 792–798.

    CAS  Article  Google Scholar 

  6. 6

    Thomson AK, Glasson EJ, Bittles AH . A long-term population-based clinical and morbidity review of Prader–Willi syndrome in Western Australia. J Intellect Disabil Res 2006; 50: 69–78.

    CAS  Article  Google Scholar 

  7. 7

    Akefeldt A, Gillberg C, Larsson C . Prader–Willi syndrome in a Swedish rural county: epidemiological aspects. Dev Med Child Neurol 1991; 33: 715–721.

    CAS  Article  Google Scholar 

  8. 8

    Vogels A, Van Den Ende J, Keymolen K, Mortier G, Devriendt K, Legius E et al. Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in Flanders. Eur J Hum Genet 2004; 12: 238–240.

    CAS  Article  Google Scholar 

  9. 9

    Goldstone AP, Beales PL . Genetic obesity syndromes. Front Horm Res 2008; 36: 37–60.

    CAS  Article  Google Scholar 

  10. 10

    McAllister CJ, Whittington JE, Holland AJ . Development of the eating behaviour in Prader–Willi syndrome: advances in our understanding. Int J Obes 2005 2011; 35: 188–197.

    CAS  Google Scholar 

  11. 11

    Griggs JL, Sinnayah P, Mathai ML . Prader–Willi syndrome: from genetics to behaviour, with special focus on appetite treatments. Neurosci Biobehav Rev 2015; 59: 155–172.

    CAS  Article  Google Scholar 

  12. 12

    Kiess W, Galler A, Reich A, Müller G, Kapellen T, Deutscher J et al. Clinical aspects of obesity in childhood and adolescence. Obes Rev Off J Int Assoc Study Obes 2001; 2: 29–36.

    CAS  Article  Google Scholar 

  13. 13

    Nordstrøm M, Paus B, Retterstøl K, Kolset SO . The prevalence of metabolic risk factors of atherosclerotic cardiovascular disease in Williams syndrome, Prader–Willi syndrome, and Down syndrome. J Intellect Dev Disabil 2016; 41: 187–196.

    Article  Google Scholar 

  14. 14

    Bingeliene A, Shapiro CM, Chung SA . Three siblings with Prader–Willi syndrome: brief review of sleep and Prader–Willi syndrome. Case Rep Neurol Med 2015; 2015: 278–287.

    Google Scholar 

  15. 15

    Elrod MG, Nylund CM, Susi AL, Gorman GH, Hisle-Gorman E, Rogers DJ et al. Prevalence of diagnosed sleep disorders and related diagnostic and surgical procedures in children with autism spectrum disorders. J Dev Behav Pediatr 2016; 37: 377–384.

    Article  Google Scholar 

  16. 16

    Schrander-Stumpel CTRM, Curfs LMG, Sastrowijoto P, Cassidy SB, Schrander JJP, Fryns J-P . Prader–Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A 2004; 124A: 333–338.

    Article  Google Scholar 

  17. 17

    Nagai T, Obata K, Tonoki H, Temma S, Murakami N, Katada Y et al. Cause of sudden, unexpected death of Prader–Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 2005; 136: 45–48.

    CAS  Article  Google Scholar 

  18. 18

    Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K et al. Growth hormone treatment and adverse events in Prader–Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf) 2006; 65: 178–185.

    CAS  Article  Google Scholar 

  19. 19

    Einfeld SL, Kavanagh SJ, Smith A, Evans EJ, Tonge BJ, Taffe J . Mortality in Prader–Willi syndrome. Am J Ment Retard 2006; 111: 193–198.

    Article  Google Scholar 

  20. 20

    Lionti T, Reid SM, Rowell MM . Prader–Willi syndrome in Victoria: mortality and causes of death. J Paediatr Child Health 2012; 48: 506–511.

    Article  Google Scholar 

  21. 21

    Bouras N, Holt G (eds.) Psychiatric and Behavioural Disorders in Intellectual and Developmental Disabilities, 2nd edn. Cambridge University Press: Cambridge, NY, USA, 2007.

    Google Scholar 

  22. 22

    Walton C, Kerr M . Prader–Willi syndrome: systematic review of the prevalence and nature of presentation of unipolar depression. Adv Ment Health Intellect Disabil 2016; 10: 172–184.

    Article  Google Scholar 

  23. 23

    Frank L . Epidemiology. When an entire country is a cohort. Science 2000; 287: 2398–2399.

    CAS  Article  Google Scholar 

  24. 24

    Pedersen KM, Christiansen T, Bech M . The Danish Health Care System: evolution—not revolution—in a decentralized system. Health Econ 2005; 14: S41–S57.

    Article  Google Scholar 

  25. 25

    Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH . The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263–268.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. 26

    Storm HH, Michelsen EV, Clemmensen IH, Pihl J . The Danish Cancer Registry—history, content, quality and use. Dan Med Bull 1997; 44: 535–539.

    CAS  Google Scholar 

  27. 27

    Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT . The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449–490.

    Article  Google Scholar 

  28. 28

    Glynn RJ, Rosner B . Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005; 162: 975–982.

    Article  Google Scholar 

  29. 29

    Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P . Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet Lond Engl 2007; 370: 1773–1779.

    Article  Google Scholar 

  30. 30

    Smith A . Death in adults with Prader–Willi syndrome may be correlated with maternal uniparental disomy. J Med Genet 2003; 40: 63e–63e.

    Article  Google Scholar 

  31. 31

    Update from the Prader–Willi Syndrome Association USA Study of Death Committee, 2015. Available from: http://www.pwsausa.org/product/2013-national-conference-scientific-abstracts/.

  32. 32

    Butler MG, Manzardo AM, Heinemann J, Loker C, Loker J . Causes of death in Prader–Willi syndrome: Prader–Willi Syndrome Association (USA) 40-year mortality survey. Genet Med Off J Am Coll Med Genet 2016; 19: 635–642.

    Google Scholar 

  33. 33

    Alonso-Martínez JL, Sánchez FJA, Echezarreta MAU . Delay and misdiagnosis in sub-massive and non-massive acute pulmonary embolism. Eur J Intern Med 2010; 21: 278–282.

    Article  Google Scholar 

  34. 34

    Smith SB, Geske JB, Morgenthaler TI . Risk factors associated with delayed diagnosis of acute pulmonary embolism. J Emerg Med 2012; 42: 1–6.

    Article  Google Scholar 

  35. 35

    Ma Q, Yao W, Chen J, Ge H, Li S, Zheng Y . Pulmonary embolism in adolescents. Chin Med J (Engl) 2012; 125: 1089–1094.

    Google Scholar 

  36. 36

    Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251–1257.

    CAS  PubMed  Google Scholar 

  37. 37

    Office of the Surgeon General (US), National Heart, Lung, and Blood Institute (US) The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Office of the Surgeon General (US): Rockville, MD, USA, 2008. Available at: http://www.ncbi.nlm.nih.gov/books/NBK44178/ (accessed 5 July 2016).

  38. 38

    Svendsen OL, Rasmussen BS . Sporadic registration of obesity as secondary diagnosis. Ugeskr Laeger 2002; 164: 3193–3195.

    PubMed  Google Scholar 

  39. 39

    Martin B-J, Chen G, Graham M, Quan H . Coding of obesity in administrative hospital discharge abstract data: accuracy and impact for future research studies. BMC Health Serv Res 2014; 14: 70.

    Article  Google Scholar 

  40. 40

    Cyr PR, Haskins AE, Holt C, Hanifi J . Weighty problems: predictors of family physicians documenting overweight and obesity. Fam Med 2016; 48: 217–221.

    PubMed  Google Scholar 

  41. 41

    Jacob JC, Armada P, Dhesi P, Elbash F, Primiano C, Estrada ED et al. Coronary artery dissection in Prader–Willi syndrome: case report and literature review. Can J Cardiol 2012; 28: 759.e9–759.e11.

    Article  Google Scholar 

  42. 42

    Page SR, Nussey SS, Haywood GA, Jenkins JS . Premature coronary artery disease and the Prader–Willi syndrome. Postgrad Med J 1990; 66: 232–234.

    CAS  Article  Google Scholar 

  43. 43

    Lamb AS, Johnson WM . Premature coronary artery atherosclerosis in a patient with Prader–Willi syndrome. Am J Med Genet 1987; 28: 873–880.

    CAS  Article  Google Scholar 

  44. 44

    Whitman BY, Accardo P . Emotional symptoms in Prader–Willi syndrome adolescents. Am J Med Genet 1987; 28: 897–905.

    CAS  Article  Google Scholar 

  45. 45

    Kim J, Yoo H, Cho S, Hong K-EM, Kim B . Behavioral characteristics of Prader–Willi syndrome in Korea: comparison with children with mental retardation and normal controls. J Child Neurol 2005; 20: 134–138.

    Article  Google Scholar 

  46. 46

    Clarke DJ, Boer H, Whittington J, Holland A, Butler J, Webb T . Prader–Willi syndrome, compulsive and ritualistic behaviours: the first population-based survey. Br J Psychiatry J Ment Sci 2002; 180: 358–362.

    CAS  Article  Google Scholar 

  47. 47

    Sedky K, Bennett DS, Pumariega A . Prader–Willi syndrome and obstructive sleep apnea: co-occurrence in the pediatric population. J Clin Sleep Med 2014; 10: 403–409.

    PubMed  PubMed Central  Google Scholar 

  48. 48

    Jennum P, Larsen P, Cerqueira CS, Schmidt T, Tønnesen P . The Danish National Database for Obstructive Sleep Apnea. Clin Epidemiol 2016; 8: 573–576.

    Article  Google Scholar 

  49. 49

    Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HMJ, Boer H, Curfs LMG, Schrander-Stumpel CTRM . The use of medical care and the prevalence of serious illness in an adult Prader–Willi syndrome cohort. Eur J Med Genet 2013; 56: 397–403.

    Article  Google Scholar 

  50. 50

    Severinsen MT, Overvad K, Johnsen SP, Dethlefsen C, Madsen PH, Tjønneland A et al. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. Br J Haematol 2010; 149: 273–279.

    CAS  Article  Google Scholar 

  51. 51

    Coloma PM, Valkhoff VE, Mazzaglia G, Nielsson MS, Pedersen L, Molokhia M et al. Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries. BMJ Open 2013; 3: 1–11.

    Article  Google Scholar 

  52. 52

    Meier SM, Bulik CM, Thornton LM, Mattheisen M, Mortensen PB, Petersen L . Diagnosed anxiety disorders and the risk of subsequent anorexia nervosa: a Danish Population Register Study. Eur Eat Disord Rev 2015; 23: 524–530.

    Article  Google Scholar 

  53. 53

    Svensson J, Lyngaae-Jørgensen A, Carstensen B, Simonsen LB, Mortensen HB, Danish Childhood Diabetes Registry. Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time. Pediatr Diabetes 2009; 10: 248–254.

    Article  Google Scholar 

  54. 54

    Nielsen GL, Sørensen HT, Pedersen AB, Sabroe S . Analyses of data quality in registries concerning diabetes mellitus—a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst 1996; 20: 1–10.

    CAS  Article  Google Scholar 

  55. 55

    Thomsen RW, Sørensen HT . Using registries to identify type 2 diabetes patients. Clin Epidemiol 2015; 7: 1–3.

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to E Hedgeman.

Ethics declarations

Competing interests

At the time of this work, Drs Malobisky and Kreher were employees of Zafgen; Dr Malobisky has financial holdings in Zafgen. Dr Fryzek, Ms Carter and Dr Hedgeman have received compensation as consultants for Zafgen. Dr Braun has received compensation as a consultant for EpidStat.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hedgeman, E., Ulrichsen, S., Carter, S. et al. Long-term health outcomes in patients with Prader–Willi Syndrome: a nationwide cohort study in Denmark. Int J Obes 41, 1531–1538 (2017). https://doi.org/10.1038/ijo.2017.139

Download citation

Further reading

Search